General Approach of Haemostasis

Slides:



Advertisements
Similar presentations
Bleeding time is a medical test done on someone to assess their platelet function, count and integrity of the blood vessels.
Advertisements

Chapter 12 Disorders of Hemostasis
General Approach of Haemostasis
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
Quantitative Fibrinogen Mr. Mohammed A. Jaber.  Fibrinogen assays are quantitative techniques to measure the amount of functional fibrinogen present.
Coagulation Time Tube Method Mr. Mohammed A. Jaber.
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Blood Course By Dr. Khidir Abdel Galil.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Coagulation Time of whole blood
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
General Approach of Haemostasis
Erythrocyte Count Normal ranges:
MIXING STUDIES General Approach of Haemostasis
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
Cardiovascular System: Blood II and III Chapter 11.
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
Blood Groups Clotting Time and Bleeding Time. Aims of the Practical To determine: 1.Blood groups. 2.Clotting time. 3.Bleeding time.
In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.
Tests to Measure Fibrin formation Mr. Mohammed A. Jaber.
Haemostasis Dr.Salah Elmalik Department of Physiology
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
To understand blood coagulation tests it is helpful to have a basic understanding of the role of the different blood clotting factors and the coagulation.
Activated Partial Thromboplastin Time (aPTT)
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Bleeding time BLEEDING TIME: the time that elapses between the puncture of the skin and the stoppage of blood oozing using a lancet. Why Do I Need a Bleeding.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Question. Will adding anticoagulants to materials that are in the coagulation process diminish the thickness of the material greatly?
Bleeding time It is the time that elapses between the puncture of the skin and the stoppage of blood oozing.
Blood Clotting In the absence of blood vessel damage, platelets are repelled from each other and from the endothelium of blood vessels. When a blood vessel.
Chapter 17 Coagulation Testing
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Lab Work 3 SDV1- Physiology II Bleeding time, clotting time and BP
Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.
Platelets (Thrombocytes)
General Approach in Investigation of Hemostasis
MLAB Coagulation Keri Brophy-Martinez
Bleeding Disorders Last update
BLOOD GROUPS.
One Stage Factor V Assay
2nd Year Medicine- Blood Module May 2008
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
General Approach in Investigation of Hemostasis
Tests for hemostasis (Practical)
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
Determination of Hematocrit (Hct) (Packed Cell Volume; PCV)
Steps in clotting mechanism
Tests for Hemostasis (Bleeding time and Clotting time)
Activated Partial Thromboplastin Time (aPTT)
Blood.
General Approach of Haemostasis
Blood #2.
Blood type, bleeding time, clotting time and osmotic fragility
General Approach in Investigation of Hemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
Enas Sabah MSc. Human Physiology
Practical Blood Bank Lab 1 ABO Grouping.
Principles of Coagulation Screening II
HEMOSTASIS (Stages of Blood Clotting)‏
Blood Physiology.
Practical Blood Bank Lab 11 Cyroglobulin.
Presentation transcript:

General Approach of Haemostasis Lecture 3: Coagulation Time of whole blood

Coagulation Time ( Clotting Time) CT. Clotting Time is the time required for blood to form a clot in vitro. The basis for the test is that whole blood will form a solid clot when exposed to a foreign surface such as a glass tube. It is a rough measure of all intrinsic clotting factors in the absence of tissue factors. Variations are wide and the test sensitivity is limited. As the test is the least effective test in the diagnosis of actual haemostasis failure, it has been replaced by PTT. Clotting time was used as a screening test to measure all stages in the intrinsic coagulation system and to monitor heparin therapy . Clotting is the formation of a jelly like substance over the valves of the vessels.

It is a complex process involving over 30 substances It is however, a time-consuming test, has poor reproducibility, is sensitive only extreme factor deficiencies. It is therefore, of limited use in today’s laboratory . It is a complex process involving over 30 substances Conditions accompanied by increased Clotting Time: Factors V, VII, VIII, IX, XI, XII Deficiencies. Hemorrhagic disease of Newborn Vitamin K deficiency. Heparin Therapy. Presence of Circulating antibodies (inhibitors) Anemia and leukemia. Afibinogenemia and Pneumonia. Reproducibility is the ability of an experiment or study to be accurately reproduced, or replicated, by someone else working independently. It is one of the main principles of the scientific method. Heparin: Works by markedly enhancing activity of antithrombin, which inhibits activated factors II, IX, X, XI, XII, kallikrein and probably VII, but doesn’t cause a true decrease in factor levels Vitamin K: prothrombin (factor II), factors VII, IX, X, protein C, protein S, and protein Z

Methods: Capillary Method. Slide Method. Tube Method.

Tube Method (Lee-White method) Reagent & equipment Water bath, 37O C. Glass test tube (10 x 75 mm) Stopwatch. Plastic syringe and 20-gauge needle. Specimen Fresh whole blood , 4 ml . Etymology: Roger I. Lee, American physician, b. 1881; Paul D. White, American physician, 1886-1973; Gk, meta, beyond, hodos, way a method of determining the length of time required for a clot to form in a test tube of venous blood. It is not specific for any coagulation disorder but is often used to monitor coagulation during heparin therapy. Because normal values and precise methodology vary, instructions are provided by most laboratories.

Procedure Label 3 glass test tube with patient name and number them, 1, 2, and 3. Perform a clean, Untraumatic venipucture using a 20-gauge needle and drawn 4 mL of blood. Remove the needle from the syringe, and fill each of the three tubes with 1 ml blood. The last 1 ml of blood may be discarded. Start the stopwatch as soon as the blood enters the syringe. Place the three test tubes in a 37°C water bath. At exactly 3 min., Remove the first tube form water bath and tilt gently to a 45° angle to see whether the blood has clotted. If Blood not clotted return it to the water bath and examine it at 30 second intervals.

Normal Range: 5 – 12 Minutes*** After the blood in the first tube has clotted, examine the second tube immediately. Then examine the 3rd one. Record the time it took the blood in the 3rd test tube to clot. Normal Range: 5 – 12 Minutes*** Since agitation and handling speed up coagulation, the clotting time test tube #3 is the reported result.

Discussion Poor venipucture technique, causing hemolysis or tissue thromboplastin to mix with the blood, shortens the clotting time. Bubbles entering the syringe when the blood sample is being obtained increase the rate of coagulation. Always tilt the tube in the same direction and at the same angle so that the blood is moving in the same pathway up the side of the tube each time. Excessive agitation of blood (occur during the transfer of the blood from the syringe to the test tube). The blood should be allowed to flow gently down the inside of the test tube and not forcefully squirted into the test tube.

At the completion of the clotting time, one tube should remain in the 37°C water bath to be checked for clot retraction. Also, this same tube may be allowed to remain in the water bath overnight and checked the next day for clot lysis. Dirty Test Tubes will affect the result. Coagulation will be retarded by the following: Temperature Below 35O C. Temperature above 45O C. Diameter of the test tube (the smaller the diameter, the more rapid the clot formation is).

ACT (Activated clotting Time) Fresh whole blood is added to a tube containing negatively charged particles and timed for the formation of a clot. The type of negatively charged particle affects the "normal" length of ACT Celite = Diatomaceous Earth: normal is 100-170 seconds Kaolin: normal is 90-150 seconds Glass particles: normal 110-190 seconds Type of machine affects normal and therapeutic values Daily calibration checks are imperative Therapeutic Range: 180-240 seconds. Diatomaceous Earth also known as diatomite or kieselgur, is a naturally occurring, soft, siliceous sedimentary rock that is easily crumbled into a fine white to off-white powder. The typical chemical composition of oven dried diatomaceous earth is 80 to 90% silica, with 2 to 4% alumina (attributed mostly to clay minerals) and 0.5 to 2% iron oxide. Kaolin It is a layered silicate mineral, with one tetrahedral sheet linked through oxygen atoms to one octahedral sheet of alumina octahedra.[4] Rocks that are rich in kaolinite are known as china clay, white clay, or kaolin.

Hemochron® Tests measured Heparin monitoring with or without Aprotinin. Sample and volume requirements Fresh whole blood- 2mL. Elite: 200µL to fill cuvette well. Controls Electronic QC Liquid quality control- normal and abnormal Reference Ranges Normal range- healthy donors RFTCA 510 tubes: 105 – 167 seconds FTK-ACT tubes: 91 – 151 seconds Normal range- cardiopulmonary bypass patients HRFTCA 510 tubes: 86 - 147 seconds FTK-ACT tubes: 89 - 153 seconds Hemochron : A warmed test tube is rotated inside the machine. As the blood clots, it displaces the magnet within the test tube. The clotting time is determined when the magnet has displaced enough to activate a proximity switch Medtronic HemoTec: A mechanical plunger is dipped in and out of a kaolin activated blood sample. The machine optically senses the time it takes the plunger to move through the specimen. Clotting is defined by the "drop time" threshold for the plunger The machines do not correlate with one another but in general the times for the Hemochron are 30% greater than the Medtronic HemoTec

Clotting Time - Capillary method Material Sterile disposable pricking needle or lancet. Stop watch Dry glass capillary tube (narrow diameter top 2 mm, minimum 10 cm long.) Cotton Swab of absorbent cotton. Spirit wetted, cotton swab. 70 % v/v ethyl alcohol Capillary action is the movement of a liquid into a tube based on its surface tension.

PROCEDURE Apply alcoholic 70 % v/v to the clean finger with cotton swab. Allow it to dry naturally. Prick the finger with usual aseptic precautions. Remove the first drop. Dip one end of the capillary into blood drop gently without pressure. (use 3-4 capillary tubes) The Timer is started when the first blood start to enter the first capillary tube. Allow to fill the capillary with blood by lowering the end of fitted capillary. (Do not suck the blood) around ¾th of its length undipped. After every 30 seconds, using stopwatch, break a small piece of capillary. Repeat breaking at regular time intervals, till fibrin thread appears at the broken end of capillary tube. Do not pull away the cut pieces ling apart and bristly. Record time interval between pricking finger and first appearance of fibrin thread at the broken ends of capillary tube. That is clotting time of blood. Don't forget to dispose of the broken tube in the SHARPS CONTAINER.

Clotting time of whole blood

Clotting Time - Slide Method The surface of the glass tube initiates the clotting process. The expected range for clotting time is 4-10 min.

Clot retraction (Obsolete test) This test measures the amount of time it takes for a blood clot to pull away from the walls of a test tube (Shrinking). The edges of the blood vessel wall at the point of injury are slowly brought together again to repair the damage. It is used to evaluate and manage blood platelet disorders, including Glanzmann's thrombasthenia So Clot retraction depends primarily on the number and activity of the blood platelets. This test is reliable only when the concentration of fibrinogen within normal limits. Normally a blood clot will begin to retract from the walls of the tube and express serum within one hour. Following clot formation, platelet within the clot can bind to the fibrin meshwork. Build-up of contractile forces within the cytoskeleton of the platelet are then transmitted outside to shrink the mass of the clot.

Glanzmann's thrombasthenia Is an abnormality of the platelets It is an extremely rare coagulopathy in which the platelets lack glycoprotein IIb/IIIa. Reduced glycoprotein IIb/IIIa causes reduced platelet aggregation and clot retraction - no fibrinogen bridging can occur, and bleeding time is significantly prolonged. Glycoprotein IIb/IIIa is an aggregation receptor expressed by thrombocytes. This receptor is activated when the thrombocyte is stimulated by ADP, epinephrine, collagen and thrombin. The GpIIb/IIIa integrin is essential to the blood coagulation since it has the ability to bind fibrinogen, fibronectin and vitronectin. Glycoprotein Ib enables the platelet to be activated by contact with the collagen-von Willebrand-complex that is exposed when the endothelial blood vessel lining is damaged and then aggregate with other thrombocytes via fibrinogen. Glanzmann's thrombasthenia can be inherited in an autosomal recessive manner[2] or acquired as an autoimmune disorder.[3]

Clot retraction test This is a measure of platelet function. The test is done in blood to which no anticoagulant has been added and is allowed to clot. Clot retraction is then looked for. Clot retraction becomes abnormal in conditions like Fibrinogen deficiency (congenital or acquired) Thrombocytopenia < 1ooooo Thrombosthenia Polycythaemia Reduced clot formation: Glanzmann thrombasthenia , DIC, hypofibrinogenemia, dysfibrinogenemia (small clot with increased red blood cell “fall-out”) Disseminated intravascular coagulation (DIC) is a serious disorder in which the proteins that control blood clotting become abnormally active.

Procedure Obtain 2 ml of blood by venipucture. Place one ml in a glass test tube in a 37oC water bath. Inspect clot at 1, 2, 4 and 24 hours after clotting. Observe for retraction, quality, and lysis of the clot. Remaining 40-60% consists of serum and red blood cell “fall-out” from clot A visual examination of the clot is made. Usually the clot retracts and expresses serum within two hours.

Interpretation of results The clot will retract from the walls of the tube until the red cell mass occupies 50% of the total volume of blood in the tube There is a variable degree of retraction or there is no retraction at all. Grades as follows: 0 : no serum extruded 1+ : 5-10% serum extruded 2+ : 10-20% serum extruded 3+ : 20-35% serum extruded 4+ : 35-50% serum extruded Results are reported as the length of time it took for the clot to retract 2-4 hrs is reported as normal After 4 hrs is reported as poor After 24 hrs is reported as no retraction

Clot lysis test The whole blood clot lysis time is used to detect increase fibrinolysis This test is only able to detect high increase in fibrinolytic activity Clot lysis testing is a measure of the presence of the clot after 24 hours (blood fibrinolysis).

Procedure At the completion of the clotting time one tube should remain in the 37 water bath A second tube is placed in the refrigerator as soon as clotted as a control The tube is test for the disappearance of clot after 4, 8 and 24 hrs If the sample becomes fluid in less than 48 hrs , the blood is poured out onto a piece of filter paper to be sure for clot disappearance

The disappearance of clot before 48 hrs means increase fibrinolysis Interpretation The disappearance of clot before 48 hrs means increase fibrinolysis After 48 hrs clot may be Comment Refrigerated tube 37 C tube Low fibrinogen Disappear Abnormal fibrinolysis (No clot lysis after 48 hrs) Still intact Nomal fibrinolysis

Thank you Next Lecture: Prothrombin Time (PT)